Latest Commercialization News

PYC Therapeutics reported a narrowed half-year loss of $22.8 million while progressing four RNA drug candidates through clinical stages. The company announced a major $653 million capital raising to extend its cash runway to 2030 and support ongoing development.

Surefire Resources has appointed Dr Andrew Whitehead as its new CEO following the resignation of Managing Director Paul Burton, signalling a fresh chapter for the mining company.

Nickel Industries reported a reduced loss after tax of $41.2 million for 2025, underpinned by steady production and strategic progress on its ENC HPAL project and sustainability initiatives.

TMK Energy Limited reveals strong pilot well results and a robust phased development plan for its Gurvantes XXXV Coal Seam Gas project in Mongolia, underpinned by independently certified resources and strategic partnerships.

BPH Global reports a modest sales dip in its ninth month due to seasonal rains and Chinese New Year effects but strengthens its Indonesian seaweed operations with a fresh A$1 million capital injection.

ADX Energy has reported encouraging flow test results from its Welchau-1 well in Austria, confirming the presence of light oil and gas condensate in the Reifling Formation. The company plans further testing to unlock the reservoir’s full potential.

Tinybeans Group announces a leadership reshuffle with Tracy Cho as Interim CEO and Rebecca White joining the Board, sharpening its focus on expanding in the lucrative U.S. family market.

Argent BioPharma has completed its largest commercial shipment of CannEpil® to Ireland, marking a key milestone in its European expansion with a delivery valued at approximately AUD 783,000. The product is fully reimbursed under Ireland’s National Health Insurance scheme, enhancing patient access for refractory epilepsy treatment.

Medallion Metals Limited has extended the deadline for its acquisition of the Forrestania Nickel Operation from IGO Limited, with completion expected by 27 February 2026. The transaction remains on track despite a few outstanding conditions.

VEEM Limited reports half-year revenue close to guidance with improved cash flow, offset by a significant $24.8 million non-cash impairment tied to its gyro product upgrade. The transition to the new Mark III gyro design has temporarily stalled sales as customers await delivery.

Rimfire Pacific Mining is on track to deliver its maiden Murga scandium Mineral Resource Estimate by the end of March 2026, buoyed by promising assay results highlighting broad mineralisation and a potentially cheaper processing route.

Clarity Pharmaceuticals reports another metastatic prostate cancer patient achieving undetectable disease markers in its Phase II SECuRE trial, reinforcing promising efficacy and safety of its Cu-SAR-bisPSMA radiopharmaceutical.